Ethical issues with newborn screening in the genomics era

Area of Science:

• Genomics
• Public Health
• Bioethics

Background:

• Technological advancements are making whole-genome sequencing (WGS) increasingly feasible for widespread application.
• Current discussions on WGS primarily focus on clinical medicine, with limited attention to its integration into public health programs.
• Newborn screening programs represent a potential early adoption site for WGS due to their established infrastructure.

Purpose of the Study:

• To explore the potential integration of whole-genome sequencing (WGS) into newborn screening programs.
• To identify and assess the ethical challenges associated with implementing WGS in the context of newborn screening.
• To provide insights into the future of genomics in public health initiatives.

Main Methods:

• Literature review of current WGS applications and newborn screening practices.
• Analysis of ethical frameworks relevant to genetic testing and public health.
• Discussion of potential policy and implementation strategies for WGS in newborn screening.

Main Results:

• WGS offers significant potential for expanding the scope of newborn screening.
• Integrating WGS into newborn screening raises complex ethical issues, including data privacy, consent, and incidental findings.
• State-run newborn screening programs may be among the first to adopt WGS.

Conclusions:

• The integration of WGS into newborn screening is a complex undertaking requiring careful ethical consideration.
• Proactive assessment of ethical issues is essential for the successful implementation of genomic technologies in public health.
• Addressing these challenges will pave the way for the responsible use of WGS in the genomics era.